chartexchange

ADXS
AYALA PHARMACEUTICALS INC
stockOTC

InactiveFeb 3, 2026
0.60355USD+5.886%(+0.03355)13,591
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
Kenneth Berlin
HQ
Princeton, New Jersey, USA
Jun 6, 2022 · 1-for-80 (reverse)
ADXS Profile

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

ADXS Performance
PeriodPriceDateChange